Efficacy and Safety of Secukinumab in Treatment of Moderate to Severe Psoriasis. J Pak Assoc Dermatol [Internet]. 2022 Mar. 29 [cited 2026 Jul. 13];32(1):9-14. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1785